Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
811 Transient EZH2 suppression by tazemetostat during in vitro expansion maintains T cell stemness and improves adoptive T cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
